Clinical Trials Browser

Phase 2 × Telmisartan × 1 year × Clear all

NCT06815497 2026-01-28

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

Phase 2 Recruiting

Ovarian Neoplasms